Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TRIM26-Mediated CBX6 Ubiquitination Triggers NETosis to Drive Bladder Cancer Tumor Growth via the CNPY2/NF-κB Signaling Pathway.

Drug development research·2026
Same journal

Extending the Eisenbarth Model: Stage 0 as a Provisional Framework for Early Risk Stratification and Prevention in Type 1 Diabetes.

Journal of diabetes research·2026
Same journal

Mediation by Lipid-Glucose Metabolic Indices in the Association Between Overweight and T2DM Among Shanghai Community-Dwelling Older Adults.

Journal of diabetes research·2026
Same journal

Postoperative Blood Glucose Spikes Predict Morbidity After Pancreatoduodenectomy.

Journal of diabetes research·2026
Same journal

Predictors of Undiagnosed Diabetes in the Bangladeshi Female Population: A Propensity Score-Weighted Machine Learning Analysis of BDHS Biomarker Data.

Journal of diabetes research·2026
Same journal

A Qualitative Exploration of the Acceptability of a Supported Self-Management Intervention for People With Type 2 Diabetes and Severe Mental Illness.

Journal of diabetes research·2026
Same journal

Multiomics Integration Prioritizes ZFP36L1 as a Candidate Susceptibility Gene Associated With Inflammatory and Angiogenic Pathways in Diabetic Retinopathy.

Journal of diabetes research·2026
See all related articles

Related Experiment Video

Updated: Jun 9, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

Identifying Diabetic Kidney Disease in Type 2 Diabetes Patients Using Explainable Machine Learning: A Case-Control

Tongtong Qiu1, Yi Bai1, Hai Zhao1

  • 1Department of Clinical Laboratory, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China, spph-sx.com.

Journal of Diabetes Research
|June 8, 2026
PubMed
Summary
This summary is machine-generated.

This study developed a machine learning model to predict diabetic kidney disease (DKD) in Type 2 diabetes patients. The Random Forest model demonstrated high accuracy, aiding early disease identification.

Keywords:
LIMESHAPdiabetic kidney diseasemachine learning modelrandom forest

More Related Videos

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Related Experiment Videos

Last Updated: Jun 9, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Area of Science:

  • Nephrology
  • Medical Informatics
  • Machine Learning

Background:

  • Diabetic kidney disease (DKD) is a major complication of Type 2 diabetes.
  • Early identification of DKD is crucial for effective management and prevention of progression.

Purpose of the Study:

  • To develop and validate a machine learning-driven predictive tool for identifying diabetic kidney disease (DKD).
  • To assess the clinical utility and key predictors of DKD using machine learning models.

Main Methods:

  • Developed and validated prediction models using data from 1463 patients.
  • Employed Least Absolute Shrinkage and Selection Operator regression for feature selection.
  • Compared Random Forest (RF), extreme gradient boosting, support vector machine, and logistic regression using AUC-ROC, AUC-PR, accuracy, and F1-score.
  • Evaluated clinical utility with decision curve and calibration analyses; interpreted feature importance using SHAP and LIME.

Main Results:

  • The full RF model achieved superior performance in screening for DKD (AUC-ROC = 0.906, AUC-PR = 0.902, accuracy = 0.830, F1 = 0.847).
  • The RF model demonstrated favorable clinical net benefit and good calibration.
  • Key predictors included urine α1-microglobulin, hypertension, 24-h urinary total protein, diabetes duration, systolic blood pressure, serum retinol-binding protein, complement C1q, and 25-hydroxyvitamin D.

Conclusions:

  • A Random Forest prediction model was successfully developed for early DKD screening.
  • The model highlights the significant roles of specific clinical and laboratory factors in predicting DKD.
  • This tool can assist in the early identification and management of diabetic kidney disease.